CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jemal Hussien Ahmed, Eyasu Makonnen, Getnet Yimer, Daniel Seifu, Abebe Bekele, Mathewos Assefa, Abraham Aseffa, Rawleigh Howe, Alan Fotoohi, Moustapha Hassan, Eleni Aklillu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2019-05-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	CYP2J2 CYP2C9 chemotherapy hematologic toxicity reduced relative dose intensity breast cancer
Accés en línia:	https://www.frontiersin.org/article/10.3389/fphar.2019.00481/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!